Pancreatic Cancer Research

ResearcherNingbo UniversityActive in the last 2 years

Jing Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2488-5021; OpenAlex author ID A5100345373. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 5

  1. Decoding neuro-tumor interactions in pancreatic cancer: mechanisms, immunosuppressive networks and therapeutic opportunities. Last author DOI 10.1186/s43556-026-00586-2↗
  2. IGF2 is upregulated by its antisense RNA to potentiate pancreatic cancer progression. Co-author DOI 10.1007/s10142-023-01277-9↗
  3. Exploring the Potential of Pyroptosis-Related Genes in Predicting Prognosis and Immunological Characteristics of Pancreatic Cancer From the Perspective of Geno… Co-author DOI 10.3389/fonc.2022.932786↗
  4. MicroRNA-18a induces epithelial-mesenchymal transition like cancer stem cell phenotype via regulating RKIP pathway in pancreatic cancer. Co-author DOI 10.21037/atm.2020.03.195↗
  5. The construction and proliferative effects of a lentiviral vector capable of stably overexpressing SPINK1 gene in human pancreatic cancer AsPC-1 cell line. Co-author DOI 10.1007/s13277-015-4405-z↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wei Cheng · 1 shared paper, 2026 · strength 0.36
  2. Xinhua Zhou · 1 shared paper, 2023 · strength 0.24
  3. Yuan Tian · 1 shared paper, 2023 · strength 0.24
  4. Guoxiong Zhou · 1 shared paper, 2022 · strength 0.22
  5. Honggang Kang · 1 shared paper, 2020 · strength 0.15
  6. Mengxiang Yang · 1 shared paper, 2020 · strength 0.15
  7. Jun Wang · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.